
    
      An open label, balanced, randomized, two-treatment, two-period, two-sequence, single dose,
      crossover, oral bioequivalence study of Montelukast sodium chewable tablets 4mg and 5mg of
      Dr. Reddy's Laboratories Limited, India comparing with that of SINGULAIRÂ® (containing
      Montelukast sodium) chewable tablets 4mg and 5 mg of Merck Sharp & Dohme Ltd., USA in
      healthy, adult, human subjects under fasting conditions.
    
  